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Cardiac healing, which follows myocardial infarction, is a complex process guided by intricate interactions among
different components. Some resident cell populations with a potential role in cardiac healing have already been
described in cardiac tissues. These non-cardiomyocyte cell subsets, globally described as cardiac pluripotent/
progenitor cells (CPCs), are able to differentiate into all three major cardiac cell lineages (endothelial, smooth muscle
and cardiomyocyte cells) in experimental settings. Nevertheless, physiological cardiac healing results in a fibrous scar,
which remains to be fully modelled experimentally. Since a role for complement anaphylatoxins (C3a and C5a) has
been described in several regeneration/repair processes, we examined the effects that C3a and C5a exert on a
defined population of CPCs. We found that C3a and C5a are able to enhance CPC migration and proliferation. In
vitro studies showed that this effect is linked to activation of telomerase mRNA and partial preservation of telomere
length, in an NFκB-dependent manner. In addition, anaphylatoxin signalling modulates the CPC phenotype,
increasing myofibroblast differentiation and reducing endothelial and cardiac gene expression. These findings may
denote that C3a and C5a are able to maintain/increase the cardiac stem cell pool within the heart, whilst
simultaneously facilitating and modulating resident cell differentiation. We found that this modulation was directed
towards scar forming cells, which increased fibroblast/myofibroblast generation and suggests that both these
anaphylatoxins could play a relevant role in the damage-coupled activation of resident cells, and regulation of the
cardiac healing process after injury.Introduction
The cardiac healing process is guided by intricate
interactions between different components; following
myocardial infarction (MI), injury, inflammation, regen-
eration, and repair are all interconnected processes. It is
known that these processes are inadequate and over-
complicated, since certain pathological or damaging
factors, such as cardiomyocyte replacement cannot be
repaired. The inflammatory response represents one* Correspondence: abernad@cnic.es; adiez@cipf.es
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reproduction in any medium, provided the origcritical element of the cardiac healing process and is
triggered by cell stress and death caused during cardiac
injury. The abolition of the inflammatory response using
corticosteroids not only decreases the number of infil-
trating leukocytes, but also delays healing and collagen
deposition (Kloner et al. 1978). Moreover it has been
shown that cardiac tissue reperfusion improves overall
tissue repair and that this outcome is mediated by im-
proving the inflammatory reaction (Frangogiannis 2012).
Over the last 30 years, the complement system has been
shown to play a major role in myocardial inflammation
and tissue injury following MI (Hill and Ward 1971;
Walport 2001) has been experimentally inhibited at differ-
ent levels, including that of anaphylatoxin (C3a, C5a) sig-
nalling, to reduce ischemic injury. Experiments usingis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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ition protects against ischemia reperfusion (I/R) injury in
diverse organs including myocardium (Vakeva et al. 1998).
While anaphylatoxin C5a has been shown to be a potent
activator of inflammation (Walport 2001), the upstream
role of anaphylatoxin C3a has shown mixed results in ani-
mal models of I/R injury. In mouse models of renal and
cerebral I/R injury, C3a appears to play a key role in medi-
ating inflammation (Mocco et al. 2006; Thurman et al.
2007), whereas other studies suggest it is less important
(Busche and Stahl 2010; Proctor et al. 2004). Moreover, in
mammals, anaphylatoxins are critical for hepatocyte
proliferation and liver regeneration (Strey et al. 2003). C3a
promotes homing, chemotaxis, and retention of
hematopoietic stem and progenitor cells in the bone mar-
row (Ratajczak et al. 2004); the anaphylatoxin receptors
(C3aR, C5aR) positively regulate adult neurogenesis as
well as the quantity of replacement neurons produced
following cerebral ischemia (Rahpeymai et al. 2006). Re-
cently, a novel and unexpected function for C3a and its
receptor C3aR has also been revealed in the mutual
cell-cell attraction (named co-attraction), required for
maintaining cohesive clusters of migrating mesenchymal
cells during early development (Carmona-Fontaine et al.
2011). The authors proposed that co-attraction and con-
tact inhibition must act in concert to allow cell clusters
to self-organise and respond efficiently to external
signals, such as chemoattractants and repellents. There-
fore anaphylatoxins seem to play both positive and nega-
tive roles depending on the physiopathological context;
hence their artificial modulation to improve healing still
requires further research.
The adult myocardium has recently been shown to
harbour multipotent progenitor cells that can give rise
to both myogenic and vasculogenic lineages, which can
both contribute to myocardial repair (reviewed in (Barile
et al. 2007; Laflamme and Murry 2011)). On the other
hand, since the myocardium has a low endogenous re-
generative competence, loss of a substantial amount of
cardiac muscle ultimately results in scar formation. In-
flammatory signals are required to guarantee the opti-
mal creation of a supportive scar in the injured tissue,
modulating phenotype function and gene expression in
fibroblasts, endothelial cells, and leukocytes which to-
gether control collagen, fibroblast/myofibroblast depos-
ition and vascular network formation. An optimal
inflammatory reaction leads to stable scar formation,
and the low regenerative potential of cardiac tissue
indicates that, at least in a physiological situation,
CPCs should behave preferentially as a healing cell popu-
lation that participates in scar formation, since they have
a very low potential for cardiomyocyte replacement.
Telomerase-competent CPCs with long telomeres are
present in the atria and apex storage regions of the heart;following activation by growth factors they migrate to
damaged areas, where they although have the potential
to create a population of young myocytes (Itzhaki-Alfia
et al. 2009) their contribution to regenerated cardiac tis-
sue is very low. Experimental data suggest that the regen-
erative potential of endogenous adult stem cells is low,
and multiple reports show that defects in telomere
maintenance impairs organ regeneration like liver
(Hartmann et al. 2011) or in haematopoietic stem cell
maintenance (Calado and Young 2008). In addition,
telomere shortening during progenitor cell proliferation
affects the function of the brain, pancreas, bone marrow,
and heart, pointing to stem cell dysfunction as a critical
determinant of organ aging/regeneration (Beausejour
and Campisi 2006; Harrington and Greider 1991). There-
fore efficient pro-regenerative signalling should modulate
telomerase activation, allowing efficient cell proliferation,
and also modulation of cell differentiation towards a
healing phenotype.
In this work we describe the role of complement
anaphylatoxins in CPC biology and prove that C3a and
C5a are able to enhance cell migration and proliferation.
This effect is linked to telomerase mRNA activity and ac-
tivation, and a partial preservation of telomere length.
Conversely anaphylatoxin stimulation influences CPC
fate, pushing them towards myofibroblast differentiation,
reduces endothelial gene expression, and increases colla-
gen and smooth muscle gene expression, thus supporting
a role for them in cardiac scar formation. Hence,
enhanced proliferation ability and telomere length
maintenance could denote that both C3a and C5a
anaphylatoxins can help to maintain the cardiac resi-
dent cell pool within the heart during injury, and fa-
cilitate their function as scar forming cells.
Results
CPC culture and characterisation
Small biopsies of murine adult hearts were placed on
gelatin/fibronectin plates (Figure 1A (1)). Following an ini-
tial outgrowth of fibroblast-like cells, within 5–7 days of
explant plating, small, round and poorly adherent cells
appeared and expanded (Figure 1A (2)). These cells, called
explant-derived cells (EDCs) could be detached by gently
pipetting, and were harvested and cultured to form
cardiospheres (Figure 1A (3)). Using immunofluorescence,
EDCs were found to express the cardiac markers, Nkx2.5,
Gata4, Cx43, and Mef2c (Figure 1B) and also cell surface
makers c-kit and Sca-1 (Figure 1B). During cardiosphere
culture, proliferative cells (Ki67 positive) were found pri-
marily in the external part of the sphere, in contrast to the
CPC marker c-kit predominately found in the core. Sca-1
was more homogenously expressed throughout the whole
culture. EDCs showed a very low expression for the vascu-
lar markers CD31 and aSMA.
Figure 1 Cardiosphere isolation and markers. A) Cardiosphere isolation protocol. Cardiac explants are seeded in fibronectin-coated plates;
after 2–3 days cells leave the explants and invade the plate where they start to proliferate. One week after, a population of loosely attached
round bright cells appears, this population give rise to cardiospheres. B) Immunofluorescence analysis for cardiac, myofibroblast and endotheial
markers in cultivated cardiospheres. Cardiospheres showed cells expresing c-kit and Sca-1. Presence of c-kit-positive cells are predominat in the
core of the culture and relatively low in places that are positive for the proliferation marker Ki67. In contrast Sca-1+ cells are present uniformly in the
whole culture. Cultures are also positive for Gata4, Cx43 and Mef2c cardiac markers. Expression of vascular markers, such as CD31 and SMA, was low.
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culture to passage 2 (p2); these cells, present within
3–4 weeks of biopsy, were termed multipotent cardiac
progenitor cells (CPCs; Figure 2A). Flow cytometry on
EDCs revealed that 84 ± 0.3% of these cells expressed
the stem cell marker c-kit, 71 ± 9% expressed Sca-1 and
11 ± 2% expressed CD45 (Figure 2B) Gene expression
was analysed using immunofluorescence and RT-PCR.
CPCs expressed the pluripotent genes Bmi1, Nestin,
Rex1, Tert, and lacked Oct4 and Sox2 expression
(Figure 2B and some early cardiac transcription factors
Tbx3, and Gata4. In order to evaluate their differenti-
ation potential, CPCs were cultured with differentiation
medium (Figure 2D and 2E) or co-cultured with neo-
natal rat cardiomyocytes (NRCMs; Figure 2F and 2G).
After 7 days in differentiation medium culture, CPCs
showed upregulation of cardiac genes such as Troponin
T and α-Actinin (Figure 2D), which was confirmed by
western-blot (Figure 2E). GFP+ CPCs were co-cultured
with NRCMs and after 7 days isolated by FACS for mo-
lecular analysis. Gene expression studies showed
upregulation of Gata4, α-Actinin, Troponin T, β-MyHC
and α-SMA (Figure 2F) and immunofluorescence ana-
lysis revealed the presence of GFP+ CPCs derived cells
expressing Tropomyosin (Figure 2G).
CPCs express functional anaphylatoxin receptors
Functional expression of the anaphylatoxin receptors
C3aR and C5aR on non-immune cells has been previ-
ously reported for other cells like neurons and astrocytes
(Van Beek et al. 2000) or mesenchymal stem cells
(Schraufstatter et al. 2009), between others. To evaluatethe potential of complement anaphylatoxins to activate
CPCs, we checked the expression of C3a and C5a
receptors on CPCs. We detected cell surface expression
of C3aR and C5aR determined by immunofluorescence
(Figure 3A), which was confirmed by Western blotting
for their respective proteins (Figure 3B). The entire cell
population expressed cell surface C3aR and C5aR in
moderate to high levels. Interestingly, densitometry
analysis of western blot membrane and normalized the
expression versus C5aR the expression of C3aR in
CPCs was 7,9 fold higher than in endothelial cells
(ECs) or 2,5 fold higher compared to mouse embry-
onic fibroblasts (MEFs). To probe the functionality of
the C3a and C5a receptors, we explored the activation
of signalling pathways known to be triggered by
anaphylatoxins in other cell types. These pathways are
the G-protein calcium-release dependent phosphoryl-
ation of PKC, and also the phosphorylation-dependent
activation of ERK1/2 (Monsinjon et al. 2003), AKT/PKB
(Schraufstatter et al. 2009), and NFkB (Pan 1998). We
found substantial activation of both the ERK and PKC
pathways, but we did not detect the phosphorylated
forms of Akt (Figure 3C). In addition C3a, and to a larger
extent C5a, were able to induce NFκB activation,
measured as the phosphorylation of IKKa (Figure 3C)
and the nuclear translocation of p65 (Figure 3D).
C3a and C5a promote CPC proliferation and migration
Proliferation and migration to damaged tissues are two im-
portant characteristics of progenitor cells that enable them
to perform their physiological role in maintaining tissue
homeostasis. In the context of cardiac homeostasis, the
Figure 2 CPCs isolation and differentiation. A) CPCs are obtained when cardiospheres are expanded as a monolayer culture in fibronectin
coated plates. B) mRNA expression of stemness (Oct4, Sox2, Bmi1, Nestin, Rex1, Tert) and early cardiac markers (Tbx3, Gata4). C) Flow cytometry
showing the expression of Sca1 c-kit and CD45 in CPCs. D) Quantitative expression analysis of cardiac, endothelial and smooth muscle markers in
CPCs exposed to differentiation medium. E) α-Actinin protein upregulation was confirmed by western-blot after 7 and 14 days in differentiation
medium (HL-1 cells protein extract was used as a control). F) Quantitative expression analysis of cardiac, endothelial and smooth muscle markers
in GFP+ CPCs after co-culture with NRCMs. G) Immunofluorescence showing GFP+ CPCs expressing Tropomyosin (white arrowheads) after 7 days
in co-culture with NRCMs.
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damage, which in turn may have an effect on any cardiac
progenitors close to the damaged area. To probe this hy-
pothesis we assessed the proliferative and migration ability
of CPCs upon C3a and C5a stimulation (Figure 4A). CPCs
were cultured in the presence of C3a and C5a, and their
proliferation rate was measured by 3H-thymidine incorp-
oration into their DNA. CPCs cultured in the presence of
C3a and C5a proliferated faster than the control cells. This
proliferation enhancement was dose dependent and peaked
at C3a = 50 nM (3-fold vs. control), and C5a = 15 nM(4-fold vs. control; Figure 4A). Moreover effect of C5a is
quite more stronger to activate migration and proliferation
than C3a. The addition of both anaphylatoxins at the
described peak concentration together the effect of C5a
overlaps C3a with out any cooperation.
In some models cell proliferation is linked to cell mi-
gration (Diez-Juan and Andres 2003). Interestingly, in
addition to the modulation of the chemotactic activity of
immune cells, C3a and C5a has also been shown to in-
duce migration of non-immune cells such as neural stem
cells (Shinjyo et al. 2009) or mesenchymal stem cells
Figure 3 CPCs possess functional complement receptors C3aR and C5aR that signal through different pathways. (A) Immunoflourescence de
C3aR (FITC) and C5aR(Cy5) on CPCs culture. B) Immunoblot of CPCs to detect C3aR and C5aR receptors. C) Immunoblot of CPCs stimulated with different
concentrations of C3a and C5a. C3a C5a stimuli activate PKC, ERK1/2 and NFκB pathways but fail to activate AKT. ERK, AKT and PKC activation are
measured as presence phosphorylated forms. NFκB activation is probed as IKK phosphorylation. D) p65 nuclear translocation. Starved CPCs were induced
with 100nM C3a or 15 nM C5a, Immunoflorescence of p65 protein reveal nuclear translocation. Serum stimulation is the positive control for activation
ERK, AKT and NFkappa Beta. Calcium ionophore is the positive control for PKC activation. MEFS =mouse embryonic fibroblasts, EC =Murine endothelial
cell line. IgG Anti C3aR-FITC (green). IgG Anti C5aR-Texas (Red). White bar: 10 μm.
Figure 4 C3a/C5a induce proliferation and migration in CPCs.
A) CPCs treated with C3a and C5a showed an increase in DNA
3H-thymidine incorporation with respect to the control. B) CPCs
migrated towards C3a and C5a gradients when migration was
assessed in a Boiden chamber assay. The optimal doses for both
proliferation and migration are C3a = 50 nM and C5a = 15 nM. Data
were normalized versus control. p≤ 0.05 (*); p≤ 0.01 (**).
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we next explored the potential of C3a and C5a as
chemotactic factors in CPCs. Using a Boyden chamber,
CPCs were placed in the upper transwell compartment
and stimulated with C3a or C5a in the lower compart-
ment (Figure 4B). Both anaphylatoxins were able to in-
duce cell migration when present at the same
concentration that induced cell proliferation in the pre-
vious assay. C5a was more efficient at inducing cell mi-
gration at lower doses; at higher concentrations the
stimulation was reduced, resulting in a bell-shaped re-
sponse curve (Figure 4B), which may be explained by
the fact that this agent primarily stimulates chemotaxis.
In fact, at higher concentrations, diffusion of C5a from
the lower to the upper compartment of the Boyden
chamber could disrupt the C5a gradient and thus
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chemoattractant that stimulates chemokinesis would not
result in a bell-shaped dose–response, since such a reac-
tion is independent of chemical gradients.Anaphylatoxins C3a and C5a induce telomerase activity
and telomere maintenance in CPCs
It is well known that cell proliferation is dependent on
telomere maintenance, which is mainly achieved through
the action of telomerase (Tert) (Choudhary et al. 2012).
Moreover, multiple experimental data show that telo-
mere length maintenance is crucial to the preservation
of the regenerative potential of adult endogenous stem
cells (reviewed in (Choudhary et al. 2012)). Thus, we
assessed if C3a and C5a could be considered as a pro-
healing stimuli by activating CPC proliferation in com-
bination with telomerase induction.
To test this idea, we measured telomerase expression
and activity in CPCs cultured in the presence of C3a
or C5a at the optimal doses of 50 nM and 15 nM re-
spectively (Figure 5A). We found, by qPCR analysis,
that CPCs cultured with C3a and C5a showed more
than a 2-fold increase in Tert mRNA (Figure 5A). This
result was confirmed by measuring telomerase activity
using a telomeric amplification protocol (TRAP). CPCs
cultured in the presence of C3a and C5a showed an
incremental increase in telomerase activity of 3-fold
and 5-fold respectively, with respect to the control
cells (Figure 5A). We next examined whether the pro-Figure 5 Telomerase analysis. A) Telomerase mRNA expression and TRAP
cultured in presence of C5a and C3a present longer telomeres than their c
centromere FISH probe Three independent experiments was analyzed. p≤
Centromere (red) Telomere (green).telomeric role of C3a and C5a anaphylatoxins is
correlated to the presence of longer telomeres than in
controls. We used a telomeric probe, normalised with a
centromeric probe, to quantify the telomere length of
CPCs grown in presence of C3a or C5a for 20 popula-
tion doublings. As shown in Figure 5B and C, C3a-
CPCs and C5a-CPCs display longer telomeres than
their control counterparts. However, this telomere
maintenance effect is not capable of completely preven-
ting telomere shortening, since C5a-CPCs at p20 have
still significantly shorter telomeres than their counter-
parts at p0. In addition, this increment was only statis-
tically significant (P = 0.001) in the C5a treated CPCs
(Figure 5B). Taken together, these results suggest that
C3a and C5a have a ‘pro-telomeric’ effect on CPCs, al-
though this is not sufficient to retain telomere length at
their initial length.The induction of TERT expression by anaphylatoxins C3a
and C5a is dependent of NFκB activation
To gain insight into the molecular mechanisms respon-
sible for C3a and C5a anaphylatoxin mediated Tert in-
duction we examined the Tert promoter and found two
NFκB binding sites. Since C3a and C5a are able to in-
duce NFκB signalling in CPCs, this molecular pathway
appeared to be a good candidate for the mediation of
C3a and C5a dependent Tert mRNA expression.
To test this possibility, we used two complemen-
tary approaches. First, we performed a chromatinactivity in CPCs cultured in presence of C3a or C5a. B and C) CPCs
ounterparts. B) Quantification of relative fluorescence of telomere vs.
0.05 (*); p≤ 0.01 (**). C) Representative figures of chromosome FISH.
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p65; we used primer pairs that cover the NFκB site
at −326-316 in the murine TERT promoter so that
we could determine if p65 is recruited to the en-
dogenous TERT promoter upon anaphylatoxin stimu-
lation. These CHiP assays confirmed that C3a/C5a
stimulation induces the recruitment of p65 to the
consensus site in the murine TERT promoter
(Figure 6B). Second, to further confirm that NFκB
was responsible, at least in part, for inducing TERT
mRNA expression in anaphylatoxin-stimulated CPCs,
we used a mutant of IκBα protein that is refractory
to IKK phosphorylation. This mutant IκBα S32/S36-A
behaves as a potent dominant negative IκBα protein
that attenuates NFκB transactivation (Brown et al.
1995). CPCs were transduced with a retroviral vector
coding for IκBα to block NFκB activation or with a
control vector, and Tert mRNA expression was
assessed by RT-qPCR. As shown in Figure 6A, at-
tenuation of NFκB activation abolishes anaphylatoxin
dependent Tert induction in CPCs. Taken together
these experiments demonstrate that NFκB is the
main signalling pathway involved in anaphylatoxin
dependent Tert expression.Figure 6 NFκB signalling mediates the induction of Tert by C3a
and C5a. A) CPCs transduced with a retroviral vector coding for mutant
IκBα that blocks NFκB activation or with a control vector and induction
of Tert mRNA expression was assessed by RT-qPCR. B) Chromatin
immunoprecipitation (CHIP) of the TERT promoter using a p65 antibody.
Input (complete extract), IgG (IgG isotipe control), a-p65 (IP of chromatin
binding sites using p65 antibody). Two different primers at the NFκB site
of Tert promoter were used mTert-NF-κB(1) and mTert-NF-κB(2). ß-actin
primers were used as a control.Anaphylatoxins C3a and C5a abolish the cardiac and
endothelial potential of CPCs and promote
myofibroblastic differentiation mediated by an
endothelial to mesenchymal transition-like process
Although some experimental results have shown a
limited regenerative response after heart injury, cardiac
wound healing in mammals is hampered by the fact that
the regeneration of heart muscle is virtually absent, and
that damaged myocardium is replaced by scar tissue.
The above results point towards pro-regenerative activity
for complement anaphylatoxins: both of them promote
CPC migration, proliferation, telomerase activity, and
telomere maintenance. All of these anaphylatoxin-
mediated processes can be envisioned to activate and ex-
pand the resident CPC pool within the heart. However,
to be effective in regenerating damaged tissue, a stem cell
pool must preserve its differentiation potential when it
proliferates. A pro-regenerative event would mean that
CPCs maintain their ability to differentiate into the main
cardiogenic lineages (smooth muscle/myofibroblast, endo-
thelium and cardiomyocytes), or are even able to enhance
their ability to differentiate towards a cardiomyocyte fate,
the main cell type that is not replenished after MI. There-
fore we examined the effect of CPC exposure to comple-
ment anaphylatoxins.
CPCs treated with either C3a or C5a (for 72 h) were
assessed, by RT-qPCR, for the expression of some well-
known endothelial, myofibroblast, and cardiomyocyte
lineage markers. We chose Gata4, Nkx2.5, Tbx5, and Tbx3
as cardiogenic markers, Actc1 as an early cardiomyocyte
marker, CD31, vWF, and E-Cadherin as endothelial
markers, Myocardin, SM22α, and TCF21 as myofibroblast
markers, and SM22α, α-SMA, Vimentin, Desmin, and
Collagen 1a (Col1a) as mature myofibroblast markers.
We found that upon anaphylatoxin stimulation, CPCs
appeared to initiate a myofibroblastic transcription pro-
gram, with a more than 5-fold increase in the pro-
myofibroblastic transcription factors Myocardin and
TCF21. In addition, there was a clear increase in the ex-
pression of the myofibroblast markers Desmin, α-SMA,
Col1a, and Vimentin, which clearly indicates differenti-
ation towards a mature myofibroblast fate (Figure 7A).
The induction of myofibroblast genes was accompanied
by a reduction of endothelial markers with more than a
3-fold decrease in the quantity of CD31 and E-Cadherin
mRNA detected, and a 2-fold decrease in the case of
vWF. It therefore seemed clear that anaphylatoxin
stimulation compromises the endothelial fate of CPCs
and promotes a clear bias towards the myofibroblastic
fate. This was further confirmed by immunofluorescence
analysis of the myofibroblast marker α-SMA, and of two
endothelial markers CD31, and the surface protein lec-
tin. As shown in Figure 6B, CPCs treated with C3a or
C5a showed increased levels of α-SMA positive cells,
Figure 7 Effects of complement anaphylatoxins upon stemness myofibroblast and cardiogenic potential of CPCs. A) C3a and C5a
induces expression of miofibroblast transcription factors (SM22a, myocardin, TCF21, α-SMA) and markers (Vimentin, Collagen and Desmin). In
other hand reduces expression of endothelial genes (CD31, vWF and E-Cadherin). Genes involved in endMT (Twist1, Snail and Fsp1) are also
induced. There is an increase in cardiogenic genes as NKx2.5, Actc1, Tbx5 and Tbx3. But Gata4 is repressed. B) Complement anaphylatoxins
induce myofibroblast differentiation. Treatment with C3a and C5a produces a marked increase in the mRNA levels of core factors involved in
myofibroblast differentiation (Myocardin, SM22alpha, TCF21) as well as in the mRNA levels of the mature myofibroblast markers SM-actin,
Desmin, Vimentin, and Col1a. B) Immunofluorescence confirms data presented in B; CPCs treated with C3a or C5a present higher number
of cells positive for SMA. As a positive control for endothelial differentiation, CPCs were cultured in Endothelial Media (EGM); in A) cells
cultured in this condition repress the expression of myofibroblast and endMT associated genes and induce the expression of the endothelial
markers. p≤ 0.05 (*); p≤ 0.01 (**).
Lara-Astiaso et al. SpringerPlus 2012, 1:63 Page 8 of 15
http://www.springerplus.com/content/1/1/63typical of myofibroblastic lineages. Conversely, CPCs
stimulated with C3a or C5a lost CD31expression and
showed a reduction in tomato-lectin binding on their
membranes. As a positive control, we cultured CPCs in
endothelial medium (EGM2) to direct endothelial differen-
tiation. At the mRNA level, this resulted in a 2.5-3-fold in-
crease in endothelial marker levels and the abolition of
myofibroblast markers (Figure 7A). Immunofluorescence
studies revealed that, with respect to the control, EGM2
cultured CPCs presented higher levels of lectin and slightly
increased levels of CD31 (Figure 7B); this mirrors the small
increase in CD31 mRNA expression in EGM2 cultured
CPCs with respect to control CPCs.
Immunofluorescence analysis showed that when CPCs
are in their multipotential state, they express moderate
levels of both myofibroblast and endothelial markers
(Figure 7) and so they can be considered as being in a
state of balance between these two fates. Complement
anaphylatoxin stimulation seems to break this balance,
pushing CPCs towards the myofibroblast lineage. We
then hypothesized about the mechanism underlying this
C3a/C5a-dependent balance shift and noticed that the
decrease in the endothelial markers could point to anendothelial to mesenchymal like transition (EndTM),
which would be capable of altering this equilibrium. To
test this hypothesis, we treated CPCs with the optimal
C3a and C5a doses and measured the mRNA levels of
two key transcription factors involved in EndMT, Snail1
and Twist1 (Huber et al. 2005). Figure 7A shows that
cells treated with C3a and C5a presented higher levels of
Twist1 (almost 2-fold) and Snail (> 5-fold) mRNAs. We
also assessed the expression of the known EndMT
marker Fsp1 and confirmed the C3a/C5a-dependent in-
duction of an EndMT-like process; CPCs treated with
these anaphylatoxins showed a 5-fold increase in the
Fsp1 mRNA levels (Figure 7A).
Therefore a likely explanation for the observed results
is that C3a and C5a promote an EndMT-like process in
CPCs that restricts their endothelial potential and pushes
them towards the mesenchymal fate inducing the expres-
sion of the myofibroblastic lineage promoters and thus
committing them to differentiate towards myofibroblasts
that express the typical markers Desmin, α-SMA and,
SM22α. In addition, the cardiogenic potential of CPCs is
abolished upon C3a and C5a stimulation, since this
negates C3a and C5a dependent commitment of CPCs
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scription factor in cardiogenesis, Gata4, was clearly
repressed upon anaphylatoxin treatment (Figure 7A);
however the expression of other cardiogenic factors did
not follow this pattern. When CPCs were treated with
C3a and C5a, we found that while Gata4 mRNA
decreased 5-fold, the mRNA levels of its downstream
factors Nkx2.5, Tbx5 and Tbx3 markedly increased (2.6
to 17-fold), along with an increase in mRNA from the
early cardiac marker Actc1, which rose by 3 - 4-fold.
Gata4 is known to be crucial for cardiomyocyte differ-
entiation; therefore, the repression of Gata4 expression
in CPCs stimulated by C3a and C5a clearly points toward
a role for these factors in the compromise of cardiogenic
differentiation potential in these CPCs. A role for C3a
and C5a in the compromise of cardiogenic differentiation
is further supported by the appearance α-SMA positive
cells and by the induction of myofibroblast markers in
C3a/C5a treated CPCs, since this process is obstructing
cardiomyocyte differentiation (Wu et al. 2006). There-
fore the C3a and C5a mediated transcriptional activa-
tion of Tbx3, Tbx5 and Nkx2.5 might suggest an
alternative role for these transcription factors in the mat-
uration of and/or functional properties of myofibroblasts.
Another interesting possibility is the implication of
these mesodermal factors in the C3a/C5a mediated
proliferation of CPCs.
Thus, we conclude that C3a and C5a promote the differ-
entiation and commitment of CPCs towards myofibroblast
lineage, blocking their cardiac and endothelial potential.
Methods
Cell culture and stimulation
Sca1+ CPCs were grown on gelatin at 0.1% (v/v) in
CSPH Media, composed of 50% Neurobasal Medium,
50% DMEM/F12, 1% 100 μg/ml penicillin and strepto-
mycin, 1% 2 mM L-Glutamine, 0.1% 250 ng/ml
Fungizone, 0.1% 50 mg/ml Gentamicin and 10% Stem
Cell Quality (ESQ)-FSB, supplemented with LIF 10 ng/ml,
1% ITS, FGF 10 ng/ml, EGF 20 ng/ml, 1% N2 and 2% B27.
C3a (FIDCCNH ITKLREQHRR DHVLGLAR) and
C5a (AFNECCTIAN KIRKESPHKP VQLGR) syn-
thetic peptides were synthetised by GeneScript USA,
NJ. Inmortalized endothelial cell line was a gift of
Dr. Alfonso Luque and has been previously described
(Hortelano et al. 2010). Mouse embryonic fibroblasts
(MEFs) were generated from mice littermates in
C57BL/6 J background harvested from embryonic
day12-13.5. Briefly, separated embryos from pregnant
mice had their heads and livers removed and
incubated at 37°C in the presence of 0.25% Trypsin/
EDTA for 5 minutes in a humidified incubator.
Trypsinized embryos were homogenized by pipetting
up and down and allowed to sediment for 5 minutes,and cells sedimenting in the lower phase were collected
and plated in fresh DMEM containing 10% FBS. If not
specified culture mediums and supplements were
obtained from Invitrogen, (Carlsbad, CA). Growth
factors were purchased from Peprotech (Oak Park, CA)
Differentiation assays
CPCs were exposed to differentiation medium for 7 and
14 days, composed of DMEM, 1% 100 μg/ml penicillin
and streptomycin, 1% 2 mM L-Glutamine, 10% Stem Cell
Quality (ESQ)-FSB and 10nM Dexamethasone. Neonatal
rat cardiomyocytes were isolated from P2 Wistar rat
hearts using the Worthington Neonatal Cardiomyocyte
Isolation System (Worthington, Lakewood, NJ). CPCs for
co-culture experiments were transduced with pRRL.CMV.
GFP lentiviral vector supernatants provided by CNIC viral
vector facility, and cells with high GFP expression were
selected by FACS. For the co-culture, NRCMs were seeded
at 7.5 × 104 cells/cm2 on 75% M199, 25% DMEM, 5% FBS,
10% HS, 1% 100 μg/ml penicillin and streptomycin and
1% 2 mM L-Glutamine, and on the next day GFP+ CPCs
were added at 3 × 103 cells/cm2.
Proliferation assay
Proliferation was measured by [3H]thymidine incorpor-
ation performed in triplicate as previously described
(Diez-Juan and Andres 2003). Briefly cell cultures were
plated on 24-well culture dishes at a density of 5 × 103
cells per well and incubated for 4 hours with [3H]thymi-
dine (1 μCi/mL, Amersham) after which cells were
washed with PBS and incubated for 1 h with ice-cold 5%
trichloroacetic acid. Labeled DNA was extracted with
0.5 N NaOH and counted in a scintillation counter
(Wallac, Turku, Finland).
Migration assay
CPCs were plated at 1 × 105 cells/well in the upper well
of a transwell (8 μm pore size, Millipore) in 250 μl of
serum free DMEM/F12 media supplemented with ITS
(Invitrogen, CA, USA). Cells were allowed to migrate to-
wards the lower transwell compartment (500 μl chemo-
tactic gradient (C3a 50 nM/C5a 15 nM) for 3 hours at
37°C. CPCs were mechanically removed from the top
side of the transwells and the membranes were fixed for
15 min with 4% PFA, stained with Prolong DAPI
(Invitrogen, CA, USA) and counted. Experiments were
performed in triplicate.
Immunofluorescence
Cells were cultured in plastic tissue cover slips and fixed
with 2% PFA. Cells were then washed twice with PBS,
blocked with 10% horse serum and incubated with anti-
bodies overnight. Specific fluorescent secondary antibodies
were use to visualise immunolabelling. We used anti-
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Acris Gmbh), anti-C3aR (sc-14624, Santa Cruz), anti-α-
SMA (1A4, A2547, Sigma) and CD31 (MEC13.3, BD
Pharmigen). Biotinilated anti goat IgG (Invitrogen) was
added after 3 washes with PBS-T. Finally anti mouse FITC
or Cy3 streptavidin (Invitrogen) was added.
Western blots
Cells were lysated with RIPA buffer. The protein con-
centration was quantified by Protein detection kit "DC
protein assay" (BIO-RAD, Hercules, CA, US), and 10 μg
of protein was loaded into a 12% acrilamide gel. The
proteins were transferred with iBlot Dry Blotting System
(Invitrogen), and the membranes were blocked with 10%
dry milk in PBS-T. The membranes were then incubated
overnight at 4°C with the primary antibody in blocking
buffer. This was followed by washing and 1 hour incu-
bation with an appropriate peroxidase-conjugated sec-
ondary antibody. Protein bands were detected by
chemiluminiscence using a commercial kit (Pierce)
according to the manufacturer’s instructions. Primary
antibodies were: anti p65, anti iKKa, anti p-IKKa anti
pERK, anti ERK1/2, anti pPKC, anti PKC, anti p-AKT
anti and AKT from Cell Signaling; rat IgG (Millipore),
anti α-Actinin murine IgG (Sigma), anti Tubulin mur-
ine IgG (BD biosciences), anti C3aR Antibody (H-300)
sc-20138 and anti C5aR(CD88) (H-100) sc-25774
(Santa Cruz Biotechnology). Secondary antibodies were
HRP-anti rat IgG (Dako) and HRP-anti mouse IgG
(Dako). If stated, densitometric analysis of the blots
was performed with ImageJ software.
RNA extraction and nonQuantitative and quantitative
real-time polymerase chain reaction (RTq-PCR)
Total RNA was extracted using the PureLink RNA Mini
Kit (Invitrogen). First strand cDNA was synthesised using
the High Capacity cDNA Reverse Transcription kit and
random hexamers (Applied Biosystems). For RTq-PCR,
samples were run in 20 μl reactions using an ABI 7900
Fast (Applied Biosystems, Foster City, CA). Samples were
incubated at 95°C for 15 min, followed by 40 cycles at
95°C for 10 s, 60°C for 20 s, and 72°C for 30 s. SYBR
Green oligonucleotides were used for detection and quan-
tification of a given gene. The relative mRNA level was
calculated after normalization to two standard housekeep-
ing genes (36B4 and GusB) using the Comparative Ct
Method as described in the manufacturer’s instructions
(Invitrogen, Carlsbad, CA). For nonQuantitative, PCR
samples were run in 15 μl reactions contained cDNA,
0.2 mM dNTP, 0.5 μM 5 and 3 oligonucleotide primers as
well as reaction buffer and 1.25 U of DNA polymerase
(HotStarTaq; Qiagen, Hilden, Germany). DNA amplifica-
tion was conducted using a thermocycler (Mastercycler;
Eppendorf, Hamburg, Germany). PCR conditions were28 cycles of 94°C (1 min), 59°C (1 min), and 72°C (1 min)
Primers are described in Table 1 and were designed using
bioinformatic methods and checked for specificity by
running the final reaction in a 2% agarose gel as well as
by obtaining their corresponding melting curves.Telomere length quantification by Q-FISH
FISH was carried out as described above, using a Cy3-
labelled LL(CCCTAA)3 peptide nucleic acid (PNA) telo-
meric probe (Euregentec) and a FITC labelled LL
(ATTCGTTGGAAACGGGA) PNA alpha satellite probe
(Eurogentec, Liège) as previously described (Samper
et al. 2001) with the following modifications. After hy-
bridisation slides were washed three times with PBS
supplemented with 0.1% Tween for 10 min at 60°C and
dehydrated through an ethanol series (70%, 90%, and
100%) for 5 min each. Slides were then counterstained and
mounted in Vectashield H-1200 mounting medium. Digital
images were acquired as described above. Telomere
signals were captured with the same exposure time in all
samples and the telomere length was represented in rela-
tive fluorescence units. Telomere signals from at least
20–30 nuclei per group were quantified using the TFL-
Telo (version 2) kindly provided by Dr Peter Lansdorp
(British Columbia Cancer Centre, Vancouver). All images
were captured and analysed in parallel on the same day
by an experimenter blinded to the treatment groups.Measurement of telomerase activity by TRAP assay
Telomerase assays were performed on 5000 CPCs as
described (Banerjee and Jagadeesh 2009), with the
following modifications. Protein extracts were made using
lysis buffer NP40 (10 mM Tris–HCl, 1 mM MgCl2, 1 mM
EDTA, 1%NP40, 0.25 mM Sodium deoxycholate, 10% gly-
cerol, 150 mM NaCl, 5 mM β-mercaptoethanol (all from
Sigma-Aldrich) and protease inhibitor 1x (Roche, Basel,
Switzerland) at pH 8.0. The protein concentration was
quantified by Protein detection kit "DC protein assay"
(BIO-RAD, Hercules, CA, US). Were incubated 5 and 1 μg
of protein per sample with telomerase extension buffer
(500 mM Tris-AcH, 500 Mm AcK. 30 mM MgCl2, 10 mM
spermin, 10 mM EGTA, 50 mM β-mercaptoethanol,
2 mM dAGT (all from Sigma-Aldrich) and 1 mM of Oligo
TS (5´ - AAT CCG TCG AGC AGA GTT −3`. Extension
reaction of telomerase (2 μl) was added to 23 μl PCR reac-
tion mix containing 1 x Power SYBR Green PCR Master
Mix, 5 mM EGTA, 2 ng/μl Oligo TS and 4 ng/μl Oligo
ACX (5´ GCG CGG C(TTACCC)4. PCR was carried out
at 94°C for 10 min followed by 40 cycles of, 94°C for 15 s
and 60°C for 1 min. PCR products were monitored with a
ABI PRISM 7700 sequence detection apparatus (Applied
Biosystem, Foster City, CA, USA) and analyzed with SDS
v2.3 software (Applied Biosystem, CA).


























SM 22 alpha Fw CCTCCAGCTCCTCGTCATAC
SM 22 alpha Rv CCTTCCAGTCCACAAACGAC
SM-actin Fw TCCCTGGAGAAGAGCTACGAACT
SM-actin Rev GATGCCGCTGACTCCAT
Snail Fw TCC AAA CCC ACT CGG ATG TGA AGA







Troponin T Fw ACCCTCAGGCTCAGGTTCA
Troponin T Rev GTGTGCAGTCCCTGTTCAGA
Twist1 F AAT TCA CAA GAA TCA GGG CGT GGG
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Chromatin immunoprecipitation (ChIP) experiments
were performed using the EZ-Magna ChIP G kit
(Millipore Corporation), according to the manufacturer's
protocol, with slight modifications. Approximately 107
CPCs were used for each experiment. Two millilitres of
cell lysate were sonicated using a Microson Ultrasonic
Cell Disruptor. Samples were kept cool in an ethanol-ice
-water bath and sonicated for four 30 s pulses with
1 min pauses between them. Fragmented chromatin was
diluted in ChIP dilution buffer (Millipore EZ-Magna
ChIP kit), distributed in 300 μl aliquots, and used dir-
ectly or stored at −80°C. The anti-p65 (ab31481) and
anti-histone H3 (ab1791) antibodies were purchased from
Abcam. Following immunoprecipitation, DNA was
analysed by real-time PCR. To identify NFκB binding sites,
3Kb upstream of murine Tert gene were analyzed using
PROMO (Messeguer et al. 2002). One site was found at
position chr13:73764072–73764172 at -322 bp of mTert
star site within dissimilarity margin less or equal than 5%.




ActinFw: CCCAAGGGGCGCATTGGCAT, ActinRw: GG
GAGGGGGCAGTCAGAGCA.
Statistical analysis
Results are reported as mean ± SD. Data were normalized
versus control. Three independent experiments were
analyzed. All values are expressed as mean ± SD. Statis-
tical analysis were performed with Student's T-test for
unpaired samples and normally distributed data sets.
Statistically significant differences were considered at
P < 0.05. (Statview, SAS Institute).
Discussion
In this study we have demonstrated that (a) CPCs ex-
press functional anaphylatoxin receptors, (b) stimulation
with C3a or C5a induces the expression of myofibroblast
differentiation markers and EndMT-like gene expression,
(c) C3a and C5a both increase CPC proliferation and
migration and (d) C3a and C5a also induce telomerase
activity (NFκB-dependent) and increase telomere main-
tenance, although not sufficiently to fully preserve telo-
mere length. Taken together these data support a role
for anaphylatoxins in CPC regulated cardiac healing and
scar formation.
The discovery of endogenous c-kit–positive CPCs has
driven a shift in cardiac biology. Work from multiple la-
boratories (revised in Barile et al. 2007; Laflamme and
Murry 2011) have documented the heart’s ability to re-
place old and dying cells, and propose that this capacity
depends on the persistence of a stem cell compartment.
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isolation of c-kit-positive CPCs was followed by a period
of doubt, reflected in studies from different laboratories
and accompanying editorials that questioned or
neglected issues related to CPC function. These
reservations regarding the role of CPCs in cardiac cell
turnover are mainly related to the limited nature of
myocyte renewal in the human heart (Bergmann et al.
2009). Although multiple studies in animal models have
suggested that the adult heart is capable of some cellular
turnover (reviewed in Choi et al. 2012), clinical evi-
dence clearly shows that regeneration is inadequate
after injury. This evidence supports the hypothesis that
endogenous CPC populations probably have a role in
cardiac homeostasis other than cardiomyocyte turnover,
since the cardiac healing response is very poor. In adult
mammals, cardiomyocyte regeneration is insufficient to
functionally renew severely injured myocardium and
consequently, scar tissue forms. Thus, the evolutionary
adapted healing processes that initially benefited cardiac
function finally results in a potentially maladaptive re-
sponse in the long term.
After a myocardial infarction, massive cell infiltration
into the myocardium results in fibrosis. MI injury is
considered an inflammatory state, characterised by in-
nate immune responses. Whereas it was initially thought
that the immune system protects the body against for-
eign or non-self signals, there is now a body of evidence
to suggest that the innate immune system is activated
following tissue injury, triggering the release of endogen-
ous ligands (Arslan et al. 2011). Participation of the
complement system in myocardial ischemia was first
demonstrated in 1971 in a rat MI model (Hill and Ward
1971). Administration of monoclonal antibodies against
C5 and C5a as well as the C5a receptor reduced myocar-
dial infarct size in pigs and rodents (Amsterdam et al.
1995; Vakeva et al. 1998; van der Pals et al. 2010; Zhang
et al. 2007). However, a study concerning patients either
undergoing percutaneous coronary intervention (PCI) or
coronary artery bypass grafting (CABG) with pexelizumab
(a single-chain fragment of a humanised monoclonal anti-
body against complement component C5) administration
showed a significant reduction in mortality in the former
case, but no benefit in patients with acute MI in the latter
case (Testa et al. 2008). It is important to note that
anaphylatoxin inhibition in these models has been
performed in an acute MI phase but that the principal role
of anaphylatoxins and their receptors here is to increase
leukocyte recruitment to the reperfused myocardium
following MI.
Since the complement system is activated in the milieu
of tissue injury, the effect of C3a and C5a on CSC mi-
gration and proliferation is of specific interest, because
these anaphylatoxins may contribute to the mobilisation,recruitment, and proliferation of cells at an injury site,
thus facilitating wound healing. Our data support the
role of anaphylatoxins in recruiting cells involved in tis-
sue healing: C3a and C5a are able to induce CPC
proliferation and migration, which supports the role of
anaphylatoxins in the control of tissue healing. Indeed,
apart from the known chemotactic role that C3a and
C5a play with regard to leukocytes, anaphylatoxins are
also chemotactic factors for other cells like mesenchymal
stem cells (Schraufstatter et al. 2009) or neural stem
cells (Shinjyo et al. 2009). Our data also shows that in
addition to this enhancement in proliferation and migra-
tion, anaphylatoxins also induce telomerase mRNA and
activity. Although addition of C5a significantly increases
telomere length compared to controls, and to a lesser
degree C3a, telomerase activity is not enough to main-
tain telomere length compared to the initial state. Inter-
estingly a large body of data has accumulated regarding
the capacity of telomerase to support roles other than
telomere preservation (reviewed in Martinez and Blasco
2011). One of these roles is the facilitation of cell growth
and proliferation. For instance, hTERT overexpression
lengthens the proliferative lifespan of human bone mar-
row stromal cells (Simonsen et al. 2002) being also able
to induce hyperplasia and hypertrophy in murine cardiac
myocytes (Kohl 2001). Moreover, ectopically expressed
hTERT confers resistance to the anti-proliferative effect
of transforming growth factor β (TGF-β) in p16-null
human mammary epithelial cells (Stampfer et al. 2001).
In addition, telomerase activation in human mammary
epithelial cells coincides with the stimulation of a cellu-
lar mitogenic program (Smith et al. 2003), indicating
that telomerase may affect epithelial cell proliferation
not only by stabilising telomeres, but also by affecting
the expression of growth-promoting genes. There is also
data that supports an extra-telomeric role for telomerase
in protection against oxidative stress; in this regard
Schraufstatter et al. (2009) demonstrated that C3a and
C5a protect MSCs from oxidative damage. This can be
translated into an in vivo scenario, where one would expect
that the anaphylatoxins would recruit healing cells to areas
of tissue injury, where these cells would encounter the pro-
duction of oxidants due to neutrophil recruitment and
reperfusion injury. Therefore all these data support a role
for anaphylatoxins in promoting the recruitment of healing
cells to areas of injury in order to restore tissue homeosta-
sis. Telomerase activity would not only improve cell
proliferation and survival but also protect cells against the
hostile environment – providing protection from apop-
tosis, oxidative stress, and DNA damage.
Injured ischemic myocardium progresses to necrosis and
subsequent healing; the local response to irreversible injury
is the formation of granulation tissue, the accumulation of
collagen, and resultant replacement fibrous scar (Sun
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that the heart has a very low endogenous capacity for re-
generation when severe damage is inflicted, multiple en-
dogenous putative cardiac stem cell or progenitor cell
populations have been identified and isolated. Markers,
traditionally associated with blood, bone marrow or pluri-
potent stem cells, have been used by several independent
groups to identify these cells in adult or postnatal hearts
in humans and other mammalian species (Smith et al.
2008). We have worked with a population (CPCs), as
described by Messina et al. (Messina et al. 2004), this
population expresses the cardiac markers, Nkx2.5, Gata4,
Cx43 and Mef2c (Figure 1B) and therefore had a putative
cardiogenic potential. Thus our first task was to under-
stand why, if these cells have the potential to differentiate
in cardiomyocytes, physiological cardiac healing usually
results as a fibrotic scar and shows very low levels of
cardiomyocyte replacement. We investigated the potential
of these cells to differentiate to all three lineages described,
and facilitated differentiation by using 10% FBS to improve
myofibroblast differentiation, and EGM on Matrigel to
increase endothelial lineage differentiation. Interestingly
anaphylatoxins repress Gata4 expression and increase the
expression of some early cardiac markers (Nkx2.5, Tbx3,
Tbx5, Actc1) in CPCs. Endothelial cell (EC) lineage differ-
entiation was clearly improved by culture on Matrigel
using EGM media and in these conditions, stimulation
with C3a and C5a anaphylatoxins reduced endothelial gene
expression. In agreement with this data, immunofluores-
cence also showed the absence of ECs in the presence of
anaphylatoxins. Inhibition of EC differentiation is
paralleled by induction of Twist and Snail genes together
with Fsp1 expression. Fsp1 is one of the markers of fibro-
blast formation and is a cytoskeletal protein belonging to
the calmodulin-S100-troponin C superfamily of intracellu-
lar calcium binding proteins associated with cytoskeletal
fibres, cell motility, and mesenchymal phenotype (Zimmer
et al. 1995). Therefore the expression of Snail1 and Twist1
genes, together with the significant increase in Fsp1 ex-
pression, indicated that an endMT-like differentiation
event might be occurring in CPCs. In addition, anaphy-
latoxins induce the expression of an array of genes asso-
ciated with myofibroblasts that probably abolishes their
role in regeneration but hints at their relevance in the car-
diac healing process that follows MI. In this scenario, com-
plement anaphylatoxins would activate migration of CPCs
to the damaged area, induce their proliferation and finally,
upon persistence of local signalling, would promote their
differentiation into myofibroblast cells that would be able
to fill and quickly repair the damaged heart area, preven-
ting further cardiac complications.
Gata4 has been proved to be a critical early factor in
cardiogenesis, it lays upstream of Tbx5, Nkx2.5, and Act1
in the cardiogenic transcription network, and acts togetherwith Baf60c to generate a chromatin state competent for
cardiogenic differentiation (Takeuchi and Bruneau 2009).
Therefore C3a and C5a may block cardiomyocyte differen-
tiation by repressing Gata4 expression. The cardiogenic
factors Nkx2.5, Actc1 and specially Tbx3 and Tbx5 may
have roles other than their cardiogenic ones, including
modulating the response of CPCs to complement
anaphylatoxins, for instance they might be involved in the
C3a/C5a dependent myofibroblast differentiation process.
It is known that several mesodermal cells (cardiomyocytes
and myofibroblasts) share parts of their transcriptional dif-
ferentiation networks, supporting the existence of a com-
mon myocardial and smooth muscle cell precursor in the
developing embryo. This is consistent with in vivo studies,
which show the co-expression of numerous smooth
muscle genes in myocardial progenitor cells (Wu et al.
2006). Therefore Tbx3 and Tbx5 would be common to
both cell types, and Gata4 levels would be critical in modu-
lating the fate decision of progenitor cells. Interestingly it
has been proposed that Gata4 expression can play a role in
the developmental regulation of cardiac fibroblasts and has
a function in the maintenance of cardiac-resident
progenitors (Jankowski 2009). This raises the hypothesis
that C3a and C5a are factors that affect CPC fate by
switching the balance of different lineage specific factors:
they shut down the expression of endothelial and cardiac
factors and induce the expression of myofibroblast factors
(TCF21, SM22α and Myocardin), irreversibly pushing
CPCs towards the myofibroblast fate.
Taken together, these findings shed some light onto
what have been described as endogenous cardiac stem
cells and some mechanistic insight about the limited po-
tential of CPCs to generate new cardiomyocytes after
cardiac injury. We can hypothesize that anaphylatoxin
release at early time after cardiac injury is able to in-
crease CPC numbers and to promote migration towards
the site of injury. This signal also increases CPC poten-
tial to differentiate into myofibroblast lineages that
would participate in scar formation. This situation gives
an advantage to cardiac tissue promoting a fast healing
in MI. Differentiation toward myofibroblast in CPCs
would make available a higher number of myofibroblasts
to contribute to other sources of myofribroblasts
(Krenning et al. 2010) during the resolution stage of MI.
This situation is different from physiological cardiac cell
turnover. During life possibly other signals in absence of
inflammatory signals will permit cardiomyocyte differen-
tiation to replace exhausted cells. Interestingly recent
evidence reported by Jianqin Ye et al. (2012) have shown
that there is a significant increase in the proliferative
capacity of CS-forming cells isolated from the “middle
aged” heart following acute MI resulting in a significant
rise in the number of CSs in vitro and this increase is
most pronounced within the first week post-MI. In
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CS cells obtained from 1-week post-MI hearts engraft in
ischemic myocardium and restore cardiac function at
25 days post-injection in vivo. However, we did not find
evidence for differentiation of these cells into mature
cardiomyocytes or new vessels althouhgt promoted
angiogenesis in vivo. Their data suggest that early signals
that happens after MI would commit these cells to a
more healing phenotype instead of regenerative fate.
To heal the heart adding new cardiomyocyte probably
is a more delicate and time-consuming situation that
mammalian wounded heart cannot go through in a wild
environment. Thus the signals involved in cardiac
healing have been selected to permit a fast healing situ-
ation increasing myofibroblast differentiation but in
other hand this impairs cardiomyocyte renewal. Deeper
understanding of these mechanisms would help to im-
prove wounded heart regeneration.
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